Hot Features
Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquit... Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for antiviral therapeutics in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -7.40740740741 | 0.405 | 0.43 | 0.36 | 219049 | 0.3747361 | DE |
| 4 | 0.005 | 1.35135135135 | 0.37 | 0.43 | 0.34 | 188972 | 0.36590066 | DE |
| 12 | 0.005 | 1.35135135135 | 0.37 | 0.48 | 0.31 | 259164 | 0.38386645 | DE |
| 26 | -0.06 | -13.7931034483 | 0.435 | 0.515 | 0.31 | 296649 | 0.40112788 | DE |
| 52 | 0.24 | 177.777777778 | 0.135 | 0.63 | 0.135 | 479083 | 0.36447075 | DE |
| 156 | 0.279 | 290.625 | 0.096 | 0.63 | 0.05 | 336451 | 0.25780062 | DE |
| 260 | 0.0775 | 26.0504201681 | 0.2975 | 0.63 | 0.05 | 246528 | 0.25653964 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.